The effects of USP5 CNV on mRNA expression were then evaluated by GISTIC analysis, and the results showed that USP5 amplification was associated with higher mRNA expression of USP5 in ovarian serous carcinomas patients (Figure 1C). Here, USP5 is linked to ovarian serous carcinoma.